RxDoctor Payments DataLook up a doctor →

Denis Nam

Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1114184058

Payments from drug & device makers

$3,691,068in general payments, 2019–2025

Across 306 payments — averaging $12,062 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3.2M
  • Zimmer Biomet$347K
  • KCI USA, Inc.$72K
  • Solventum Corporation$33K
  • Convatec Inc.$1K
  • Johnson & Johnson$60
$18,801in research payments, 2019–2025

Across 1 payment — averaging $18,801 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$19K

What the payments were for

  • Royalty or licence$3,031,45695%
  • Consulting fees$109,9253%
  • Travel & lodging$40,6221%
  • Food & beverage$5,3650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker267$3,238,881
Zimmer Biomet21$346,774
KCI USA, Inc.13$71,841
Solventum Corporation3$32,500
Convatec Inc.1$1,013
Johnson & Johnson1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,691,068 in reported general payments places this provider in the 95th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$796,056
Medicare patients
929
Services billed
9,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin393$2,617
Oxycodone Hcl387$2,327
Tramadol Hcl717$2,201
Mupirocin341$1,912
Meloxicam532$1,439
Cefadroxil227$1,290
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen107$1,108
Celecoxib27$824
Amoxicillin483$620
Ondansetron Hcl60$221
Pregabalin15$214
Clindamycin Hcl84$170
Diclofenac Sodium27$143
Methylprednisolone22$74
Zolpidem Tartrate11$35

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →